Summary
Abstract:
What’s New for 2022?
Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year
Global Fiducial Markers Market to Reach $141.1 Million by 2027
In the changed post COVID-19 business landscape, the global market for Fiducial Markers estimated at US$102.4 Million in the year 2020, is projected to reach a revised size of US$141.1 Million by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027. Metal, one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$63.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Polymer segment is readjusted to a revised 4.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $27.9 Million, While China is Forecast to Grow at 7.8% CAGR
The Fiducial Markers market in the U.S. is estimated at US$27.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$29.4 Million by the year 2027 trailing a CAGR of 7.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$18.7 Million by the year 2027.
Other Product Types Segment to Record 3.7% CAGR
In the global Other Product Types segment, USA, Canada, Japan, China and Europe will drive the 3.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$17.7 Million in the year 2020 will reach a projected size of US$22.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 4% CAGR through the analysis period.
Select Competitors (Total 42 Featured) -
Beekley Corporation
Best Medical International, Inc.
Boston Scientific Corporation
Carbon Medical Technologies
CIVCO Radiotherapy
Eckert & Ziegler
IBA
Innomedicus AG
Innovative Oncology Solutions
IZI Medical Products
JJ-Medtech
Meditronix Corporation
Medtronic
Nanovi A/S
Naslund Medical AB
QFIX
QlRad Inc.
Seedos Ltd
Stellar Medical
Varian Medical Systems, Inc.
Table of contents
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Fiducial Markers - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Fiducial Markers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Fiducial Markers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 3: World 15-Year Perspective for Fiducial Markers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027
Table 4: World Recent Past, Current & Future Analysis for Metal
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR
Table 5: World Historic Review for Metal by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Metal by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Polymer by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2020 through 2027 and % CAGR
Table 8: World Historic Review for Polymer by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Polymer by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis for
Cancer Research Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Cancer Research Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 12: World 15-Year Perspective for Cancer Research Centers
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Hospitals & Outpatient Facilities by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Hospitals & Outpatient
Facilities by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Hospitals & Outpatient
Facilities by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027
Table 16: World Recent Past, Current & Future Analysis for
Independent Radiotherapy Centers by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Independent Radiotherapy
Centers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Independent
Radiotherapy Centers by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027
Table 19: World Recent Past, Current & Future Analysis for CT /
CBCT by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR
Table 20: World Historic Review for CT / CBCT by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for CT / CBCT by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 22: World Recent Past, Current & Future Analysis for MRI
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR
Table 23: World Historic Review for MRI by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for MRI by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 25: World Recent Past, Current & Future Analysis for
Ultrasound by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2020 through 2027 and % CAGR
Table 26: World Historic Review for Ultrasound by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for Ultrasound by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 28: World Recent Past, Current & Future Analysis for
Radiotherapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ for Years
2020 through 2027 and % CAGR
Table 29: World Historic Review for Radiotherapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Radiotherapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 31: World Fiducial Markers Market Analysis of Annual
Sales in US$ for Years 2012 through 2027
Table 32: World Recent Past, Current & Future Analysis for
Other Product Types by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
for Years 2020 through 2027 and % CAGR
Table 33: World Historic Review for Other Product Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 34: World 15-Year Perspective for Other Product Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Fiducial Markers Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2022 (E)
Table 35: USA Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 36: USA Historic Review for Fiducial Markers by Product
Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 37: USA 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 38: USA Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 39: USA Historic Review for Fiducial Markers by End-Use -
Cancer Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 40: USA 15-Year Perspective for Fiducial Markers by
End-Use - Percentage Breakdown of Value Sales for Cancer
Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers for the Years 2012, 2021 &
2027
Table 41: USA Recent Past, Current & Future Analysis for
Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and
Radiotherapy - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 42: USA Historic Review for Fiducial Markers by Modality -
CT / CBCT, MRI, Ultrasound and Radiotherapy Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 43: USA 15-Year Perspective for Fiducial Markers by
Modality - Percentage Breakdown of Value Sales for CT / CBCT,
MRI, Ultrasound and Radiotherapy for the Years 2012, 2021 &
2027
CANADA
Table 44: Canada Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 45: Canada Historic Review for Fiducial Markers by
Product Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 46: Canada 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 47: Canada Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 48: Canada Historic Review for Fiducial Markers by
End-Use - Cancer Research Centers, Hospitals & Outpatient
Facilities and Independent Radiotherapy Centers Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 49: Canada 15-Year Perspective for Fiducial Markers by
End-Use - Percentage Breakdown of Value Sales for Cancer
Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers for the Years 2012, 2021 &
2027
Table 50: Canada Recent Past, Current & Future Analysis for
Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and
Radiotherapy - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 51: Canada Historic Review for Fiducial Markers by
Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 52: Canada 15-Year Perspective for Fiducial Markers by
Modality - Percentage Breakdown of Value Sales for CT / CBCT,
MRI, Ultrasound and Radiotherapy for the Years 2012, 2021 &
2027
JAPAN
Fiducial Markers Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2022 (E)
Table 53: Japan Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 54: Japan Historic Review for Fiducial Markers by Product
Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 55: Japan 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 56: Japan Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 57: Japan Historic Review for Fiducial Markers by End-Use -
Cancer Research Centers, Hospitals & Outpatient Facilities
and Independent Radiotherapy Centers Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 58: Japan 15-Year Perspective for Fiducial Markers by
End-Use - Percentage Breakdown of Value Sales for Cancer
Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers for the Years 2012, 2021 &
2027
Table 59: Japan Recent Past, Current & Future Analysis for
Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and
Radiotherapy - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 60: Japan Historic Review for Fiducial Markers by
Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 61: Japan 15-Year Perspective for Fiducial Markers by
Modality - Percentage Breakdown of Value Sales for CT / CBCT,
MRI, Ultrasound and Radiotherapy for the Years 2012, 2021 &
2027
CHINA
Fiducial Markers Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2022 (E)
Table 62: China Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 63: China Historic Review for Fiducial Markers by Product
Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 64: China 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 65: China Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 66: China Historic Review for Fiducial Markers by End-Use -
Cancer Research Centers, Hospitals & Outpatient Facilities
and Independent Radiotherapy Centers Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR
Table 67: China 15-Year Perspective for Fiducial Markers by
End-Use - Percentage Breakdown of Value Sales for Cancer
Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers for the Years 2012, 2021 &
2027
Table 68: China Recent Past, Current & Future Analysis for
Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and
Radiotherapy - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 69: China Historic Review for Fiducial Markers by
Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 70: China 15-Year Perspective for Fiducial Markers by
Modality - Percentage Breakdown of Value Sales for CT / CBCT,
MRI, Ultrasound and Radiotherapy for the Years 2012, 2021 &
2027
EUROPE
Fiducial Markers Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2022 (E)
Table 71: Europe Recent Past, Current & Future Analysis for
Fiducial Markers by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR
Table 72: Europe Historic Review for Fiducial Markers by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR
Table 73: Europe 15-Year Perspective for Fiducial Markers by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027
Table 74: Europe Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 75: Europe Historic Review for Fiducial Markers by
Product Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 76: Europe 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 77: Europe Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 78: Europe Historic Review for Fiducial Markers by
End-Use - Cancer Research Centers, Hospitals & Outpatient
Facilities and Independent Radiotherapy Centers Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 79: Europe 15-Year Perspective for Fiducial Markers by
End-Use - Percentage Breakdown of Value Sales for Cancer
Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers for the Years 2012, 2021 &
2027
Table 80: Europe Recent Past, Current & Future Analysis for
Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and
Radiotherapy - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 81: Europe Historic Review for Fiducial Markers by
Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 82: Europe 15-Year Perspective for Fiducial Markers by
Modality - Percentage Breakdown of Value Sales for CT / CBCT,
MRI, Ultrasound and Radiotherapy for the Years 2012, 2021 &
2027
FRANCE
Fiducial Markers Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2022 (E)
Table 83: France Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 84: France Historic Review for Fiducial Markers by
Product Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 85: France 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 86: France Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 87: France Historic Review for Fiducial Markers by
End-Use - Cancer Research Centers, Hospitals & Outpatient
Facilities and Independent Radiotherapy Centers Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 88: France 15-Year Perspective for Fiducial Markers by
End-Use - Percentage Breakdown of Value Sales for Cancer
Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers for the Years 2012, 2021 &
2027
Table 89: France Recent Past, Current & Future Analysis for
Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and
Radiotherapy - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 90: France Historic Review for Fiducial Markers by
Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 91: France 15-Year Perspective for Fiducial Markers by
Modality - Percentage Breakdown of Value Sales for CT / CBCT,
MRI, Ultrasound and Radiotherapy for the Years 2012, 2021 &
2027
GERMANY
Fiducial Markers Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2022 (E)
Table 92: Germany Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 93: Germany Historic Review for Fiducial Markers by
Product Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 94: Germany 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 95: Germany Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 96: Germany Historic Review for Fiducial Markers by
End-Use - Cancer Research Centers, Hospitals & Outpatient
Facilities and Independent Radiotherapy Centers Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 97: Germany 15-Year Perspective for Fiducial Markers by
End-Use - Percentage Breakdown of Value Sales for Cancer
Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers for the Years 2012, 2021 &
2027
Table 98: Germany Recent Past, Current & Future Analysis for
Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and
Radiotherapy - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 99: Germany Historic Review for Fiducial Markers by
Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 100: Germany 15-Year Perspective for Fiducial Markers by
Modality - Percentage Breakdown of Value Sales for CT / CBCT,
MRI, Ultrasound and Radiotherapy for the Years 2012, 2021 &
2027
ITALY
Table 101: Italy Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 102: Italy Historic Review for Fiducial Markers by
Product Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 103: Italy 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 104: Italy Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 105: Italy Historic Review for Fiducial Markers by
End-Use - Cancer Research Centers, Hospitals & Outpatient
Facilities and Independent Radiotherapy Centers Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 106: Italy 15-Year Perspective for Fiducial Markers by
End-Use - Percentage Breakdown of Value Sales for Cancer
Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers for the Years 2012, 2021 &
2027
Table 107: Italy Recent Past, Current & Future Analysis for
Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and
Radiotherapy - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 108: Italy Historic Review for Fiducial Markers by
Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 109: Italy 15-Year Perspective for Fiducial Markers by
Modality - Percentage Breakdown of Value Sales for CT / CBCT,
MRI, Ultrasound and Radiotherapy for the Years 2012, 2021 &
2027
UNITED KINGDOM
Fiducial Markers Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2022 (E)
Table 110: UK Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 111: UK Historic Review for Fiducial Markers by Product
Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 112: UK 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 113: UK Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 114: UK Historic Review for Fiducial Markers by End-Use -
Cancer Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Table 115: UK 15-Year Perspective for Fiducial Markers by
End-Use - Percentage Breakdown of Value Sales for Cancer
Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers for the Years 2012, 2021 &
2027
Table 116: UK Recent Past, Current & Future Analysis for
Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and
Radiotherapy - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 117: UK Historic Review for Fiducial Markers by Modality -
CT / CBCT, MRI, Ultrasound and Radiotherapy Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 118: UK 15-Year Perspective for Fiducial Markers by
Modality - Percentage Breakdown of Value Sales for CT / CBCT,
MRI, Ultrasound and Radiotherapy for the Years 2012, 2021 &
2027
SPAIN
Table 119: Spain Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 120: Spain Historic Review for Fiducial Markers by
Product Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 121: Spain 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 122: Spain Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 123: Spain Historic Review for Fiducial Markers by
End-Use - Cancer Research Centers, Hospitals & Outpatient
Facilities and Independent Radiotherapy Centers Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 124: Spain 15-Year Perspective for Fiducial Markers by
End-Use - Percentage Breakdown of Value Sales for Cancer
Research Centers, Hospitals & Outpatient Facilities and
Independent Radiotherapy Centers for the Years 2012, 2021 &
2027
Table 125: Spain Recent Past, Current & Future Analysis for
Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and
Radiotherapy - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 126: Spain Historic Review for Fiducial Markers by
Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 127: Spain 15-Year Perspective for Fiducial Markers by
Modality - Percentage Breakdown of Value Sales for CT / CBCT,
MRI, Ultrasound and Radiotherapy for the Years 2012, 2021 &
2027
RUSSIA
Table 128: Russia Recent Past, Current & Future Analysis for
Fiducial Markers by Product Type - Metal, Polymer and Other
Product Types - Independent Analysis of Annual Sales in US$ for
the Years 2020 through 2027 and % CAGR
Table 129: Russia Historic Review for Fiducial Markers by
Product Type - Metal, Polymer and Other Product Types Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR
Table 130: Russia 15-Year Perspective for Fiducial Markers by
Product Type - Percentage Breakdown of Value Sales for Metal,
Polymer and Other Product Types for the Years 2012, 2021 & 2027
Table 131: Russia Recent Past, Current & Future Analysis for
Fiducial Markers by End-Use - Cancer Research Centers,
Hospitals & Outpatient Facilities and Independent Radiotherapy
Centers - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR
Table 132: Russia Historic Review for Fiducial Markers by
Please contact our Customer Support Center to get the complete Table of Contents
Methodology
Our market research methodology is designed to provide the clients with comprehensive and accurate information on various
industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data
analysis etc.
The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials.
This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted
with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then
combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried
out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to
understand the market dynamics in specific regions and countries.
Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends,
and its future potential.
Related Topics